Abstract
According to the model of “response to injury”, the arterial endothelium is occasionally injured in hyperlipidemia, hypertension, diabetes mellitus and in other states known as risk factors. The ensuing inflammatory response is modulated by cytokines and growth factors, among them platelet-derived growth factor (PDGF), and monocyte chemoattractant protein-1 (MCP-1). In two independent studies, we demonstrated that mRNA levels for PDGF-A and-B and for MCP-1 are reduced after ingestion of n−3 fatty acids by human volunteers. This reduction persists after monocyte stimulation/differentiation by adherence. Moreover, the reduction is brought about only by dietary n−3 fatty acids and not by other calsses of unsaturated fatty acids (n−6 or n−9). This appears to be one major mechanism of action of reduced progression/increased regression of establihed coronary artery disease by ingestion of 1.5 g/d n−3 fatty acids, as assessed by coronary angiography in a randomized placebo-controlled double-blind intervention study in 223 patients. The study was conducted according to “Good Clinical Practice”, comprehensive rules regulating investigations with pharmaceutical compounds. Together, our investigations lend support to the importance of PDGF-A, PDGF-B, and MCP-1 in the pathogenesis of atherosclerosis, and the beneficial role of n−3 fatty acids therein.
Similar content being viewed by others
Abbreviations
- DHA:
-
docosahexaenoic acid
- EPA:
-
eicosapentaenoic acid
- HB-EGF:
-
heparin-bound epidermal growth factor
- 12-HETE:
-
12-hydroxyeicosatetraenoic acid
- IL:
-
interleukin
- LDL:
-
low density lipoprotein
- MCP-1:
-
monocyte chemoattractant protein-1
- 3n-PCR:
-
nested, nonoverlappring nonradioactive reverse transcriptase (RT)-polymerase chain reaction
- PDGF-A and PDGF-B:
-
platelet-derived growth factors-A and-B
References
Ross, R. (1993) The Pathogenesis of Atherosclerosis: A Perspective for the 1990s, Nature 362, 801–809.
Ross, R. (1999) Atherosclerosis—An Inflammatory Disease, N. Engl. J. Med. 340, 115–126.
Witztum, J.L. (1994) The Oxidation Hypothesis of Atherosclerosis, Lancet 344, 793–795.
Busse, R., and Fleming, I. (1996) Endothelial Dysfunction in Atherosclerosis, J. Vasc. Res. 33, 181–194.
Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J.R., Insull, W. Jr., Rosenfeld, M.E., Schaffer, S.A., Schwartz, C.J., Wagner, W.D., and Wissler, R.W. (1994) A Definition of Initial, Fatty Streak, and Intermediate Lesions of Atherosclerosis. A Report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association, Arterioscler. Thromb. 15, 840–856.
Stary, H.C., Chandler, A.B., Dinsmore, R.E., Fuster, V., and Glagov, S., Insull, W., Jr., Rosenfeld, M.E., Schwartz, C.J., Wagner, W.D., and Wissler, R.W. (1995) A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis. A Report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Arterioscler. Thromb. Vasc. Biol. 15, 1512–1531.
Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D., and Lusis, A.J. (1995) Atherosclerosis, Basic Mechanisms, Oxidation, Inflammation, and Genetics, Circulation 91, 2488–2496.
Bauters, C., Six, I., Meurice, T., and VanBelle, E. (1999) Growth Factors and Endothelial Dysfunction, Durgs 58, 11–15.
Goppelt-Struebe, M., and Stroebel, M. (1995) Synergistic Induction of Monocyte Chemoattractant Protein-1 (MCP-1) by Platelet-Derived Growth Factor and Interleukin-1, FEBS Lett. 374, 375–378.
von Schacky, C. (1987) Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty Acids. A Comprehensive Strategy, Ann. Intern. Med. 107, 890–899.
von Schacky, C. (2000) n−3 Fatty Acids and the Prevention of Coronary Atherosclerosis, Am. J. Clin. Nutr. 71 (Suppl. 1), 224S-227S.
Angerer, P., and von Schacky, C. (2000) n−3 Polyunsaturated Fatty Acids and the Cardiovascular System, Curr. Opin. Lipidol. 11, 57–63.
Kaminski, W., Jendraschak, E., Kiefl, R., and von Schacky, C. (1993) Dietary ω-3 Fatty Acids Lower Levels of Platelet-Derived Growth Factor mRNA in Human Mononuclear Cells, Blood 81, 1871–1879.
Baumann, K.H., Hessel, F., Larass, I., Müller, T., Angerer, P., Kiefl, R., and von Schacky, C. (1999) Dietary ω-3, ω-6, and ω-9 Unsaturated Fatty Acids and Growth Factor and Cytokine Gene Expression in Unstimulated and Stimulated Monocytes. A Randomized Volunteer Study, Arterioscler. Thromb. Vasc. Biol. 19, 59–66.
von Schacky, C., Angerer, P., Kothny, W., Theisen, K., and Mudra, H. (1999) The Effect of Dietary ω-3 Fatty Acids on Coronary Atherosclerosis. A Randomized, Double-Blind, Placebo-Controlled Trial, Ann. Intern. Med. 130, 554–562.
Jendraschak, E., Kaminski, W.E., Hessel, F., Kiefl, R., and von Schacky, C. (1993) Growth Factor mRNA Profiles in Unstimulated Human Mononuclear Cells: Identification of Genes Which Are Constitutively and Variably Expressed, Biochem. Biophys. Res. Commun. 196, 25–31.
Bull, N.L., Day, M.J.L., Burt, R., and Buss, D.H. (1983) Individual Fatty Acids in the British Household Food Supply, Hum. Nutr. Appl. Nutr. 37A, 373–377.
Reiber, J.H.C., and Serruys, P.W. (1991) Quantitative Coronary Angiography, in Cardiac Imaging: A Companion to Braunwald's Heart Disease (Marcus, M.L., Schelbert, H.R., Skorton, D.J., and Wolf, G.L., eds.), pp. 211–280, W.B. Saunders, Philadelphia.
Hausleiter, J., Jost, S., Nolte, C.W., Dirschinger, J., Kastrati, A., Stiel, G.M., Wunderlich, W., Fischer, F., Linderer, T., Hausmann, D., and Schomig, A. (1997) Comparative in vitro Validation of Eight First- and Second-Generation Quantitative Coronary Angiography Systems, Coron. Artery Dis. 8, 83–90
Angerer, P., Kothny, W., and von Schacky, C. (1998) Dietary ω-3 Fatty Acids and Human Carotid Atherosclerosis in Patients with Coronary Artery Disease: Results of a Randomized Double-Blind Two-Year Intervention Trial, Eur. Heart J. 19 (Suppl. 125) (abstract).
DeCaterina, R., Cybulsky, M.I., Clinton, S.K., Gimbrone, M.A., and Libby, P. (1994) The Omega-3 Fatty Acid Docosahexaenoate Reduces Cytokine-Induced Expression of Proatherogenic and Proinflammatory Proteins in Human Endotherlial Cells, Arterioscler. Thromb. 14, 1829–1836.
DeCaterina, R., Cybulsky, M.A., Clinton, S.K., Gimbrone, M.A., and Libby, P. (1995) Omega-3 Fatty Acids and Endotherlial Leukocyte Adhesion Molecules, Prostaglandins Leukot. Essent. Fatty Acids 52, 191–195.
Jump, D.B., Clarke, S.D., Thelen, A., Liimatta, M., Ren, B., and Badin, M. (1996) Dietary Polyunsaturated Fatty Acid Regulation of Gene Transcription, Prog. Lipid Res. 35, 227–241.
Danesch, U., Weber, P.C., and Sellmayer, A. (1996) Differential Effects of n−6 and n−3 Polyunsaturated Fatty Acids on Cell Growth and Early Gene Expression in Swiss 3T3 Fibroblasts, J. Cell. Physiol. 168, 618–624.
Brown, B.G., Zhao, X.-Q., and Albers, J.J. (1995) Regression of Atherosclerosis. Does It Occur and Does It Have a Clinical Meaning? Eur. Heart J. 16 (Suppl. E), 2–5.
Sacks, F.M., Stone, P.H., Gibson, C.M., Silverman, D.I., Rosner, B., and Pasternak, R.C. (1995) Controlled Trial of Fish Oil for Regression of Human Coronary Atherosclerosis, J. Am. Coll. Cardiol. 25, 1492–1498.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
von Schacky, C., Baumann, K. & Angerer, P. The effect of n−3 fatty acids on coronary atherosclerosis: Results from SCIMO, an angiographic study, background and implications. Lipids 36 (Suppl 1), S99–S102 (2001). https://doi.org/10.1007/s11745-001-0689-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-001-0689-5